Literature DB >> 22110299

Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

M Exindari1, D Chatzidimitriou, A Melidou, G Gioula, L Ziogou, E Diza.   

Abstract

Background. Parvovirus B19 infects children and adults, often causing erythema infectiosum, polyarthritis, but also aplastic crisis in patients with chronic haemolytic anaemia, rash, fever and fetal hydrops or fetal death. This study aims at the detection of acute parvovirus B19 infections during 2006-2009 in northern Greece on epidemiological and clinical aspect.Material and methods. Specimens were obtained from 63 patients, who addressed to hospitals, suspected for acute parvovirus B19 infection (17 in 2006, 29 in 2007, 10 in 2008 and 7 in 2009). Thirty (47.6%) were children (one day - 15 years old) and 33 (52.4%) were adults (16-65 years old). The infection was shown by PCR in whole blood and/or pleural fluid and supported by detection of specific IgM antibodies in the patients' blood serum, which was performed by ELISA.Results. Twenty (31.7%) out of the 63 specimens were found to be positive: 3/17 (17.6 %) in 2006, 16/29 (55.2 %) in 2007, none in 2008 and 1/7 (14.3%) in 2009, p=0.0002. Positive children were found 10/30 (33.3%) and positive adults 10/33 (30.3%). Specific IgM antibodies were detected in all 20 positive patients. Children developed hematological disorders, mainly types of anemia (6 cases), hydrothorax/ascites (2 cases), arthritis (1 case), and liver transplant rejection (1 case). Adults were presented with pregnancy complications (2 cases), arthralgia/arthritis (4 cases), febrile syndromes (3 cases) and atypical rash (1 case).Conclusions. In conclusion, an annual variation in the circulation of parvovirus B19 was noticed, presenting an increase of acute infections in northern Greece during 2007. Regarding serious cases, although children and adults seemed equally affected, differences in clinical manifestations were observed between them, with hematological dysfunctions predominant in childhood.

Entities:  

Keywords:  IgM; molecular; parvovirus B19

Year:  2011        PMID: 22110299      PMCID: PMC3209680     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  14 in total

Review 1.  Parvovirus B19: an expanding spectrum of disease.

Authors:  B Cohen
Journal:  BMJ       Date:  1995-12-09

2.  Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.

Authors:  Brian D Poole; Jing Zhou; Amy Grote; Adam Schiffenbauer; Stanley J Naides
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 3.  Human parvovirus B19 infection in organ transplant recipients.

Authors:  S Marchand; G Tchernia; C Hiesse; G Tertian; J Cartron; F Kriaa; S Boubenider; C Goupy; D Lecointe; B Charpentier
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

Review 4.  Erythema infectiosum and parvovirus B19 infection in pregnancy. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1988-10-01       Impact factor: 8.262

5.  Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.

Authors:  J Mossong; N Hens; V Friederichs; I Davidkin; M Broman; B Litwinska; J Siennicka; A Trzcinska; P VAN Damme; P Beutels; A Vyse; Z Shkedy; M Aerts; M Massari; G Gabutti
Journal:  Epidemiol Infect       Date:  2007-10-24       Impact factor: 2.451

6.  Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.

Authors:  Loris Pironi; Francesca Bonvicini; Paolo Gionchetti; Antonia D'Errico; Fernando Rizzello; Catia Corsini; Laura Foroni; Giorgio Gallinella
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

Review 7.  Parvovirus B19: its role in chronic arthritis.

Authors:  Ines Colmegna; Noah Alberts-Grill
Journal:  Rheum Dis Clin North Am       Date:  2009-02       Impact factor: 2.670

8.  [Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection].

Authors:  B Frotscher; S Salignac; L Morlon; C Bonmati; H Jeulin; V Venard; T Lecompte
Journal:  Ann Biol Clin (Paris)       Date:  2009 May-Jun       Impact factor: 0.459

9.  Acute arthropathy in patients with rash diseases: a comparative study.

Authors:  Solange Artimos de Oliveira; Luiz Antonio Bastos Camacho; Letícia Fernandes Bruno; Rodrigo Coimbra de Gusmão; Antonio Carlos de Medeiros Pereira; Luis Guillermo Coca Velarde; Marilda Mendonça Siqueira
Journal:  Clin Rheumatol       Date:  2009-05-05       Impact factor: 3.650

10.  High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy.

Authors:  Richard H Beigi; Harold C Wiesenfeld; Daniel V Landers; Hyagriv N Simhan
Journal:  Infect Dis Obstet Gynecol       Date:  2008
View more
  3 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection.

Authors:  Zacharias Fasoulakis; Panagiotis Antsaklis; Emmanuel N Kontomanolis
Journal:  Case Rep Obstet Gynecol       Date:  2017-07-12

3.  First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan.

Authors:  Sayed Hamid Mousavi; Niloofar Khairkhah; Tina Delsouz Bahri; Ali Anvar; Alireza Azizi Saraji; Bita Behnava; Seyed Moayed Alavian; Ali Namvar
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.